Minnie Sarwal
Director Ejecutivo en Nephrosant, Inc. .
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Mark Capone | M | 61 |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 3 años |
| Joshua Yang | M | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 7 años |
| STEVE PHILLIPS | M | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 4 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Lee Roy McCracken | M | 66 |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | - |
| Michele A. Colucci | F | - |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | 3 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 5 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Minnie Sarwal
- Red Personal
